These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 19578749)

  • 1. Use of IHC and newly designed matriptase inhibitors to elucidate the role of matriptase in pancreatic ductal adenocarcinoma.
    Uhland K; Siphos B; Arkona C; Schuster M; Petri B; Steinmetzer P; Mueller F; Schweinitz A; Steinmetzer T; Van De Locht A
    Int J Oncol; 2009 Aug; 35(2):347-57. PubMed ID: 19578749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro inhibition of matriptase prevents invasive growth of cell lines of prostate and colon carcinoma.
    Förbs D; Thiel S; Stella MC; Stürzebecher A; Schweinitz A; Steinmetzer T; Stürzebecher J; Uhland K
    Int J Oncol; 2005 Oct; 27(4):1061-70. PubMed ID: 16142324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel biomarker for staging human prostate adenocarcinoma: overexpression of matriptase with concomitant loss of its inhibitor, hepatocyte growth factor activator inhibitor-1.
    Saleem M; Adhami VM; Zhong W; Longley BJ; Lin CY; Dickson RB; Reagan-Shaw S; Jarrard DF; Mukhtar H
    Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):217-27. PubMed ID: 16492908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling.
    Xue A; Xue M; Jackson C; Smith RC
    Int J Biochem Cell Biol; 2009; 41(8-9):1731-8. PubMed ID: 19433314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The kinase Mirk/Dyrk1B mediates cell survival in pancreatic ductal adenocarcinoma.
    Deng X; Ewton DZ; Li S; Naqvi A; Mercer SE; Landas S; Friedman E
    Cancer Res; 2006 Apr; 66(8):4149-58. PubMed ID: 16618736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human pancreatic ribonuclease 1: expression and distribution in pancreatic adenocarcinoma.
    Peracaula R; Cleary KR; Lorenzo J; de Llorens R; Frazier ML
    Cancer; 2000 Sep; 89(6):1252-8. PubMed ID: 11002220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pericellular activation of hepatocyte growth factor by the transmembrane serine proteases matriptase and hepsin, but not by the membrane-associated protease uPA.
    Owen KA; Qiu D; Alves J; Schumacher AM; Kilpatrick LM; Li J; Harris JL; Ellis V
    Biochem J; 2010 Feb; 426(2):219-28. PubMed ID: 20015050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the serine protease matriptase and its inhibitor HAI-1 in epithelial ovarian cancer: correlation with clinical outcome and tumor clinicopathological parameters.
    Oberst MD; Johnson MD; Dickson RB; Lin CY; Singh B; Stewart M; Williams A; al-Nafussi A; Smyth JF; Gabra H; Sellar GC
    Clin Cancer Res; 2002 Apr; 8(4):1101-7. PubMed ID: 11948120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuromedin U is overexpressed in pancreatic cancer and increases invasiveness via the hepatocyte growth factor c-Met pathway.
    Ketterer K; Kong B; Frank D; Giese NA; Bauer A; Hoheisel J; Korc M; Kleeff J; Michalski CW; Friess H
    Cancer Lett; 2009 May; 277(1):72-81. PubMed ID: 19118941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulated histone deacetylase 1 expression in pancreatic ductal adenocarcinoma and specific siRNA inhibits the growth of cancer cells.
    Gao DJ; Xu M; Zhang YQ; Du YQ; Gao J; Gong YF; Man XH; Wu HY; Jin J; Xu GM; Li ZS
    Pancreas; 2010 Oct; 39(7):994-1001. PubMed ID: 20467347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of COX-2 is associated with accumulation of p53 in pancreatic cancer: analysis of COX-2 and p53 expression in premalignant and malignant ductal pancreatic lesions.
    Hermanova M; Trna J; Nenutil R; Dite P; Kala Z
    Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):732-9. PubMed ID: 18617777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensives as novel antineoplastics: angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor blockers in pancreatic ductal adenocarcinoma.
    Arafat HA; Gong Q; Chipitsyna G; Rizvi A; Saa CT; Yeo CJ
    J Am Coll Surg; 2007 May; 204(5):996-1005; discussion 1005-6. PubMed ID: 17481528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detailed tissue expression of bcl-2, bax, bak and bcl-x in the normal human pancreas and in chronic pancreatitis, ampullary and pancreatic ductal adenocarcinomas.
    Evans JD; Cornford PA; Dodson A; Greenhalf W; Foster CS; Neoptolemos JP
    Pancreatology; 2001; 1(3):254-62. PubMed ID: 12120204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The androgen-regulated type II serine protease TMPRSS2 is differentially expressed and mislocalized in prostate adenocarcinoma.
    Lucas JM; True L; Hawley S; Matsumura M; Morrissey C; Vessella R; Nelson PS
    J Pathol; 2008 Jun; 215(2):118-25. PubMed ID: 18338334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of proline-directed protein kinase F(A) inhibits the malignant growth of human pancreatic ductal adenocarcinoma.
    Fu HH; Yang SD
    Anticancer Res; 2004; 24(3a):1489-94. PubMed ID: 15274314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible role of matriptase in the diagnosis of ovarian cancer.
    Johnson MD; Oberst MD; Lin CY; Dickson RB
    Expert Rev Mol Diagn; 2003 May; 3(3):331-8. PubMed ID: 12779007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expression of matrix metalloproteinases-2 and -9 and their tissue inhibitor 2 in pancreatic ductal and ampullary carcinoma and their relation to angiogenesis and clinicopathological parameters.
    Giannopoulos G; Pavlakis K; Parasi A; Kavatzas N; Tiniakos D; Karakosta A; Tzanakis N; Peros G
    Anticancer Res; 2008; 28(3B):1875-81. PubMed ID: 18630474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of membrane-bound serine proteinase matriptase as processing enzyme of insulin-like growth factor binding protein-related protein-1 (IGFBP-rP1/angiomodulin/mac25).
    Ahmed S; Jin X; Yagi M; Yasuda C; Sato Y; Higashi S; Lin CY; Dickson RB; Miyazaki K
    FEBS J; 2006 Feb; 273(3):615-27. PubMed ID: 16420484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of Ezrin, HGF, C-met in pancreatic cancer and non-cancerous pancreatic tissues of rats.
    Tan XG; Yang ZL
    Hepatobiliary Pancreat Dis Int; 2010 Dec; 9(6):639-44. PubMed ID: 21134835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epithelial MMP-2 expression correlates with worse prognosis in pancreatic cancer.
    Juuti A; Lundin J; Nordling S; Louhimo J; Haglund C
    Oncology; 2006; 71(1-2):61-8. PubMed ID: 17377415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.